Pfizer to test third dose, tweaked vaccine to target S.African strain

EU leaders seek to inject energy into slow vaccine rollout
25 February 2021
Nationwide study shows BNT162b2 mRNA vaccine is effective
25 February 2021

Pfizer to test third dose, tweaked vaccine to target S.African strain

Pfizer and BioNTech said Thursday they are studying adding a third dose to their vaccine regime and testing a new version targeting the South African variant of the coronavirus.

Comments are closed.